Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Shares Sold by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC reduced its position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 34.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 123,908 shares of the real estate investment trust’s stock after selling 65,215 shares during the quarter. Nisa Investment Advisors LLC owned approximately 0.05% of Sabra Health Care REIT worth $1,768,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of SBRA. JPMorgan Chase & Co. grew its position in Sabra Health Care REIT by 709.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 13,504,420 shares of the real estate investment trust’s stock valued at $188,252,000 after acquiring an additional 11,835,109 shares in the last quarter. Norges Bank acquired a new position in Sabra Health Care REIT in the 4th quarter valued at about $26,809,000. Balyasny Asset Management LLC grew its position in Sabra Health Care REIT by 6,220.5% in the 3rd quarter. Balyasny Asset Management LLC now owns 2,136,468 shares of the real estate investment trust’s stock valued at $28,030,000 after acquiring an additional 2,102,666 shares in the last quarter. State Street Corp grew its position in Sabra Health Care REIT by 18.1% in the 1st quarter. State Street Corp now owns 12,035,766 shares of the real estate investment trust’s stock valued at $179,213,000 after acquiring an additional 1,840,939 shares in the last quarter. Finally, Balyasny Asset Management L.P. acquired a new position in Sabra Health Care REIT in the 1st quarter valued at about $12,879,000. 99.40% of the stock is owned by institutional investors and hedge funds.

Sabra Health Care REIT Stock Performance

Shares of SBRA opened at $13.75 on Friday. The stock has a 50 day moving average price of $14.02 and a 200 day moving average price of $14.05. The company has a quick ratio of 3.41, a current ratio of 3.41 and a debt-to-equity ratio of 0.86. The company has a market capitalization of $3.18 billion, a price-to-earnings ratio of 275.00, a price-to-earnings-growth ratio of 4.94 and a beta of 1.16. Sabra Health Care REIT, Inc. has a 52-week low of $10.30 and a 52-week high of $14.91.

Sabra Health Care REIT Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, February 29th. Investors of record on Tuesday, February 13th were issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 8.73%. The ex-dividend date of this dividend was Monday, February 12th. Sabra Health Care REIT’s dividend payout ratio (DPR) is 2,400.00%.

Wall Street Analyst Weigh In

SBRA has been the subject of several research reports. Deutsche Bank Aktiengesellschaft assumed coverage on Sabra Health Care REIT in a research report on Tuesday, January 30th. They issued a “buy” rating and a $21.00 target price for the company. Mizuho boosted their price objective on Sabra Health Care REIT from $15.00 to $17.00 and gave the stock a “buy” rating in a research report on Wednesday, January 3rd. Finally, Wedbush reissued an “outperform” rating and set a $17.00 price objective on shares of Sabra Health Care REIT in a research report on Thursday, February 29th. Five research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $15.54.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.